News

Onko-Sure is a simple, non-invasive, patent-pending and regulatory-approved in-vitro diagnostic test for the monitoring of colorectal cancer and for lung cancer detection and treatment monitoring by measuring the

HBI-8000 has now entered into a Phase I clinical trial in the US under an IND application with the FDA. HBI-8000 trial is designed to assess safety, tolerability

Xerclear, a patented combination of 5% acyclovir and 1% hydrocortisone in Medivir’s proprietary cream formulation, is a topical product for the treatment of recurrent herpes labialis. As per

The facility is housed with three Clinical Pharmacology Units with an 80 bed facility to cater to both early and late phase development as well as life cycle

The agreement was signed by the companies to evaluate the replication of an undisclosed virus in Vivalis’ EB66 cell line for the manufacturing of human vaccines developed by

Fostamatinib (previously referred to as R788), is thought to reversibly block signalling in multiple cell types involved in inflammation and tissue degradation in RA. The first anticipated regulatory

Before joining the company, Guggenhime served as senior vice president and CFO of at Facet Biotech and as PDL BioPharma as senior vice president and CFO. During his

The company has posted a net loss of $4.24m for the fourth quarter 2010, or $0.40 loss per diluted share, compared to net loss of $200,530, or $0.02loss

The Vector TFC Roll Compactor is a versatile densification and dry granulation machine that produces uniform compacted sheets with consistent hardness and increased density by compacting powdered material